|Acceleron Speaker:||John Knopf, Ph.D., Chief Executive Officer of Acceleron|
|Date:||March 4, 2014|
|Time:||8:40 AM (EST)|
|Location:||Salon H, 4 th Floor, Marriott Copley Place|
There's little to substantiate the president-elect's claim that he will bring drug prices down, but biotech investors are trading anyway.
I spent the weekend with thousands of blood disease researchers. This is what happened.
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.